🇺🇸 FDA
Pipeline program

ICT-107

ICT-107-201

Phase 3 mab completed

Quick answer

ICT-107 for Glioblastoma Multiforme is a Phase 3 program (mab) at PRECISION BIOSCIENCES INC with 2 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Glioblastoma Multiforme
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials